Loading viewer...
earnings
Format: PDF earnings
Third quarter 2016 earnings presentation from a biopharmaceutical company developing prodrug product candidates. The presentation discusses clinical trial plans, regulatory approval strategies including FDA 505(b)(2) pathways and expedited review opportunities, and the company's intellectual property position.
investor_presentation
18 Pages
earnings
37 Pages
Deutsche Telekom
Maple Leaf Foods Q1 2021 Earnings Review
earningsearnings
27 Pages
Maple Leaf Foods
Ellington Residential Mortgage REIT Q2 2016 Earnings Conference Call
earningsearnings
26 Pages
Ellington Residential Mortgage REIT